1. Home
  2. FBK vs IDYA Comparison

FBK vs IDYA Comparison

Compare FBK & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBK
  • IDYA
  • Stock Information
  • Founded
  • FBK 1906
  • IDYA 2015
  • Country
  • FBK United States
  • IDYA United States
  • Employees
  • FBK N/A
  • IDYA N/A
  • Industry
  • FBK Major Banks
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FBK Finance
  • IDYA Health Care
  • Exchange
  • FBK Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • FBK 2.1B
  • IDYA 1.9B
  • IPO Year
  • FBK 2016
  • IDYA 2019
  • Fundamental
  • Price
  • FBK $45.67
  • IDYA $21.23
  • Analyst Decision
  • FBK Hold
  • IDYA Strong Buy
  • Analyst Count
  • FBK 5
  • IDYA 13
  • Target Price
  • FBK $54.00
  • IDYA $53.42
  • AVG Volume (30 Days)
  • FBK 188.3K
  • IDYA 1.1M
  • Earning Date
  • FBK 07-14-2025
  • IDYA 08-05-2025
  • Dividend Yield
  • FBK 1.67%
  • IDYA N/A
  • EPS Growth
  • FBK 14.69
  • IDYA N/A
  • EPS
  • FBK 2.73
  • IDYA N/A
  • Revenue
  • FBK $465,280,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • FBK $35.47
  • IDYA $101.20
  • Revenue Next Year
  • FBK $20.14
  • IDYA $286.70
  • P/E Ratio
  • FBK $16.63
  • IDYA N/A
  • Revenue Growth
  • FBK 2.18
  • IDYA N/A
  • 52 Week Low
  • FBK $38.00
  • IDYA $13.45
  • 52 Week High
  • FBK $58.88
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • FBK 56.49
  • IDYA 62.23
  • Support Level
  • FBK $44.26
  • IDYA $21.08
  • Resistance Level
  • FBK $45.46
  • IDYA $22.37
  • Average True Range (ATR)
  • FBK 0.81
  • IDYA 0.92
  • MACD
  • FBK 0.17
  • IDYA -0.09
  • Stochastic Oscillator
  • FBK 76.03
  • IDYA 61.72

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: